| DIRECT COMPETITOR COMPARISON | |
| SNT | AMGN | NVS | SYT | Industry | | Market Cap: | 9.64M | 57.54B | 126.17B | 26.18B | 98.96M | | Employees: | 16 | 16,700 | 99,000 | 24,000 | 68 | | Qtrly Rev Growth (yoy): | N/A | -1.60% | 2.40% | -8.80% | 19.70% | | Revenue (ttm): | 75.00K | 14.58B | 42.31B | 10.98B | 14.01M | | Gross Margin (ttm): | 100.00% | 84.99% | 72.61% | 48.94% | 65.67% | | EBITDA (ttm): | -4.41M | 6.71B | 11.24B | 2.21B | -12.30M | | Oper Margins (ttm): | -6,027.60% | 38.71% | 21.50% | 16.37% | -137.11% | | Net Income (ttm): | -4.73M | 4.74B | 7.59B | 1.25B | N/A | | EPS (ttm): | -0.239 | 4.585 | 3.34 | 2.66 | -0.33 | | P/E (ttm): | N/A | 12.40 | 16.63 | 21.13 | 17.26 | | PEG (5 yr expected): | N/A | 1.31 | 2.88 | N/A | 1.28 | | P/S (ttm): | 128.51 | 3.95 | 2.98 | 2.38 | 9.45 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.85 | 0.00% | 57.54B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.18 | 0.00% | 13.93B | 16.12 | | Genzyme Corp. | GENZ | 49.98 | 0.00% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.59 | 0.00% | 41.93B | 18.02 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.64 | 0.00% | 9.03B | 1033.47 | | Teva Pharmaceutical Industries Limited | TEVA | 54.01 | 0.00% | 47.58B | 49.41 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.90 | 0.00% | 4.02B | 19.54 | | King Pharmaceuticals Inc. | KG | 11.72 | 0.00% | 2.91B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.99 | 0.00% | 5.50B | 110.37 | | Pfizer Inc. | PFE | 18.49 | 0.00% | 149.21B | 15.36 | | Johnson & Johnson | JNJ | 64.36 | 0.00% | 177.58B | 14.06 | | GlaxoSmithKline plc | GSK | 42.75 | 0.00% | 108.37B | 13.49 | | Sanofi-Aventis | SNY | 39.38 | 0.00% | 102.83B | N/A | | Novartis AG | NVS | 55.55 | 0.00% | 126.17B | 16.63 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.42 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.30 | 0.00% | 67.13B | 9.30 | | Abbott Laboratories | ABT | 53.78 | 0.00% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.14 | 0.00% | 49.80B | 13.01 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | AMGN | | Nplate(R) Data From MDS Studies Presented at ASH
Sun 1:21pm -
PR Newswire | | • | NVS | | Astra-Zeneca Flies to JUPITER on Drug Results
Sun 9:04am -
at Seeking Alpha | | • | NVS | | Novartis Could Be the Biggest Loser in Alcon Deal with Nestle
Sun 7:50am -
at Seeking Alpha | | • | AMGN | | Better Biotech Buy: Celgene or Genzyme?
Sun 12:11am -
at Motley Fool | | • | SYT | | [$$] DuPont Delay Doesn't Boost Monsanto Much
Fri, Dec 4 -
at Barrons.com | | • | NVS | | Baxter Receives H1N1 Vaccine Order
Fri, Dec 4 -
Zacks.com | | • | NVS | | Bayer Advances on Alzheimer's Plan
Fri, Dec 4 -
Zacks.com | | • | AMGN | | Biggest Cash Positions of the S&P
Fri, Dec 4 -
at CNBC | | • | AMGN | | Why Biologics Remain Expensive
Fri, Dec 4 -
at Forbes.com | | • | AMGN | | Jazz Pharmaceuticals appoints ARCA exec as CFO
Thu, Dec 3 -
AP | | • | NVS | | Novartis cleared by EC for a COPD treatment
Thu, Dec 3 -
at MarketWatch | | • | NVS | | Tired of Waiting, Teva Advances
Wed, Dec 2 -
at Motley Fool | | • | NVS | | Stem Cell Stocks Explode Higher on NIH Announcement
Wed, Dec 2 -
Indie Research | | • | NVS | | H1N1: What It Means for Pharma
Wed, Dec 2 -
at Seeking Alpha | | • | SYT | | Planting the SEED: China Watch
Wed, Dec 2 -
TheStreet.com TV | | • | SYT | | 150% Increase In Gold Prices Over Next Four To Five Years Says Money Manager: Buy Copper, Silver And Agricultural Commodities Too
Wed, Dec 2 -
Wall Street Transcript | | • | SYT | | Genetically Modified Crops: Good for Monsanto, Less So for You
Wed, Dec 2 -
at Seeking Alpha | | • | SYT | | [video] Planting the SEED: China Watch
Wed, Dec 2 -
at TheStreet.com | | • | NVS | | UBS ups Europe pharma rating to overweight
Wed, Dec 2 -
at MarketWatch | | • | NVS | | 5-Star Stocks on the Upswing
Tue, Dec 1 -
at Motley Fool | | • | SYT | | Beijing Gives Nod to Modified Rice
Mon, Nov 30 -
at The Wall Street Journal Online | | | All Headlines for these symbols... |
|
|
|
0.22% Nasdaq 0.00%
Competitors
